ATHE
Price
$3.89
Change
-$0.02 (-0.51%)
Updated
Jul 10 closing price
Capitalization
57.78M
EYPT
Price
$11.06
Change
+$0.10 (+0.91%)
Updated
Jul 10 closing price
Capitalization
754.18M
19 days until earnings call
Interact to see
Advertisement

ATHE vs EYPT

Header iconATHE vs EYPT Comparison
Open Charts ATHE vs EYPTBanner chart's image
Alterity Therapeutics
Price$3.89
Change-$0.02 (-0.51%)
Volume$36.32K
Capitalization57.78M
EyePoint Pharmaceuticals
Price$11.06
Change+$0.10 (+0.91%)
Volume$531.15K
Capitalization754.18M
ATHE vs EYPT Comparison Chart in %
Loading...
ATHE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
EYPT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ATHE vs. EYPT commentary
Jul 11, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ATHE is a Hold and EYPT is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 11, 2025
Stock price -- (ATHE: $3.89 vs. EYPT: $11.06)
Brand notoriety: ATHE and EYPT are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ATHE: 109% vs. EYPT: 66%
Market capitalization -- ATHE: $57.78M vs. EYPT: $754.18M
ATHE [@Biotechnology] is valued at $57.78M. EYPT’s [@Biotechnology] market capitalization is $754.18M. The market cap for tickers in the [@Biotechnology] industry ranges from $314.48B to $0. The average market capitalization across the [@Biotechnology] industry is $2.43B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ATHE’s FA Score shows that 0 FA rating(s) are green whileEYPT’s FA Score has 1 green FA rating(s).

  • ATHE’s FA Score: 0 green, 5 red.
  • EYPT’s FA Score: 1 green, 4 red.
According to our system of comparison, EYPT is a better buy in the long-term than ATHE.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ATHE’s TA Score shows that 5 TA indicator(s) are bullish while EYPT’s TA Score has 4 bullish TA indicator(s).

  • ATHE’s TA Score: 5 bullish, 4 bearish.
  • EYPT’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, ATHE is a better buy in the short-term than EYPT.

Price Growth

ATHE (@Biotechnology) experienced а -6.27% price change this week, while EYPT (@Biotechnology) price change was +13.79% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +10.19%. For the same industry, the average monthly price growth was +16.32%, and the average quarterly price growth was +20.67%.

Reported Earning Dates

ATHE is expected to report earnings on Feb 28, 2025.

EYPT is expected to report earnings on Oct 29, 2025.

Industries' Descriptions

@Biotechnology (+10.19% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
EYPT($754M) has a higher market cap than ATHE($57.8M). EYPT YTD gains are higher at: 48.456 vs. ATHE (17.523). ATHE has higher annual earnings (EBITDA): -19.88M vs. EYPT (-144.55M). EYPT has more cash in the bank: 318M vs. ATHE (4.54M). ATHE has less debt than EYPT: ATHE (106K) vs EYPT (24.1M). EYPT has higher revenues than ATHE: EYPT (56M) vs ATHE (0).
ATHEEYPTATHE / EYPT
Capitalization57.8M754M8%
EBITDA-19.88M-144.55M14%
Gain YTD17.52348.45636%
P/E RatioN/AN/A-
Revenue056M-
Total Cash4.54M318M1%
Total Debt106K24.1M0%
FUNDAMENTALS RATINGS
ATHE vs EYPT: Fundamental Ratings
ATHE
EYPT
OUTLOOK RATING
1..100
969
VALUATION
overvalued / fair valued / undervalued
1..100
88
Overvalued
60
Fair valued
PROFIT vs RISK RATING
1..100
10088
SMR RATING
1..100
10097
PRICE GROWTH RATING
1..100
4336
P/E GROWTH RATING
1..100
10018
SEASONALITY SCORE
1..100
n/a50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

EYPT's Valuation (60) in the Pharmaceuticals Major industry is in the same range as ATHE (88) in the Biotechnology industry. This means that EYPT’s stock grew similarly to ATHE’s over the last 12 months.

EYPT's Profit vs Risk Rating (88) in the Pharmaceuticals Major industry is in the same range as ATHE (100) in the Biotechnology industry. This means that EYPT’s stock grew similarly to ATHE’s over the last 12 months.

EYPT's SMR Rating (97) in the Pharmaceuticals Major industry is in the same range as ATHE (100) in the Biotechnology industry. This means that EYPT’s stock grew similarly to ATHE’s over the last 12 months.

EYPT's Price Growth Rating (36) in the Pharmaceuticals Major industry is in the same range as ATHE (43) in the Biotechnology industry. This means that EYPT’s stock grew similarly to ATHE’s over the last 12 months.

EYPT's P/E Growth Rating (18) in the Pharmaceuticals Major industry is significantly better than the same rating for ATHE (100) in the Biotechnology industry. This means that EYPT’s stock grew significantly faster than ATHE’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ATHEEYPT
RSI
ODDS (%)
N/A
Bearish Trend 1 day ago
85%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
82%
Bearish Trend 1 day ago
88%
Momentum
ODDS (%)
Bullish Trend 1 day ago
62%
Bullish Trend 1 day ago
90%
MACD
ODDS (%)
Bearish Trend 1 day ago
87%
Bullish Trend 1 day ago
85%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
89%
Bullish Trend 1 day ago
83%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 1 day ago
83%
Advances
ODDS (%)
Bullish Trend 8 days ago
73%
Bullish Trend 1 day ago
86%
Declines
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 11 days ago
88%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
78%
Bearish Trend 1 day ago
76%
Aroon
ODDS (%)
Bullish Trend 1 day ago
84%
Bullish Trend 1 day ago
87%
View a ticker or compare two or three
Interact to see
Advertisement
ATHE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
EYPT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
BYDIY217.007.74
+3.70%
Byd Electronic International Co Ltd.
FJTCY43.50N/A
N/A
Fujitec Co Ltd.
MHIVF0.09N/A
N/A
Invesque Inc.
WEBC185.00N/A
N/A
Webco Industries, Inc.
AILIH64.20N/A
N/A
Ameren Illinois Company

ATHE and

Correlation & Price change

A.I.dvisor indicates that over the last year, ATHE has been loosely correlated with EYPT. These tickers have moved in lockstep 54% of the time. This A.I.-generated data suggests there is some statistical probability that if ATHE jumps, then EYPT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ATHE
1D Price
Change %
ATHE100%
-0.51%
EYPT - ATHE
54%
Loosely correlated
+0.91%
SLDB - ATHE
38%
Loosely correlated
-1.81%
TECX - ATHE
37%
Loosely correlated
+0.79%
BCLI - ATHE
33%
Loosely correlated
-1.61%
CVM - ATHE
29%
Poorly correlated
+36.43%
More

EYPT and

Correlation & Price change

A.I.dvisor indicates that over the last year, EYPT has been loosely correlated with OCUL. These tickers have moved in lockstep 59% of the time. This A.I.-generated data suggests there is some statistical probability that if EYPT jumps, then OCUL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To EYPT
1D Price
Change %
EYPT100%
+0.91%
OCUL - EYPT
59%
Loosely correlated
+2.97%
LYRA - EYPT
58%
Loosely correlated
-2.58%
RXRX - EYPT
55%
Loosely correlated
+2.24%
CRSP - EYPT
54%
Loosely correlated
-1.80%
ATHE - EYPT
54%
Loosely correlated
-0.51%
More